Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CSTL Castle Biosciences, Inc.

未开盘 07-08 16:00:00 EDT

19.76

+0.30

+1.54%

盘后19.76

+0.000.00%

16:29 EDT

最高19.86	最低19.21	成交量40.06万
今开19.50	昨收19.46	日振幅3.34%
总市值5.71亿	流通市值5.23亿	总股本2,887万
成交额786.95万	换手率1.51%	流通股本2,649万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CSTL","market":"US","secType":"STK","nameCN":"Castle Biosciences, Inc.","latestPrice":19.76,"timestamp":1752004800000,"preClose":19.46,"halted":0,"volume":400644,"hourTrading":{"tag":"盘后","latestPrice":19.76,"preClose":19.76,"latestTime":"16:29 EDT","volume":9002,"amount":177877.62,"timestamp":1752006541636},"delay":0,"floatShares":26486950,"shares":28872315,"eps":-0.184478,"marketStatus":"未开盘","change":0.3,"latestTime":"07-08 16:00:00 EDT","open":19.5,"high":19.86,"low":19.21,"amount":7869513.55104,"amplitude":0.033402,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.184478,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752048000000},"marketStatusCode":0,"adr":0,"listingDate":1564027200000,"exchange":"NASDAQ","adjPreClose":19.46,"preHourTrading":{"tag":"盘前","latestPrice":19.28,"preClose":19.46,"latestTime":"09:28 EDT","volume":12,"amount":231.36,"timestamp":1751981338960},"postHourTrading":{"tag":"盘后","latestPrice":19.76,"preClose":19.76,"latestTime":"16:29 EDT","volume":9002,"amount":177877.62,"timestamp":1752006541636},"volumeRatio":1.021755,"impliedVol":0.5434,"impliedVolPercentile":0.168},"requestUrl":"/m/hq/s/CSTL","defaultTab":"news","newsList":[{"id":"2544958439","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544958439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544958439?lang=zh_cn&edition=full","pubTime":"2025-06-17 22:11","pubTimestamp":1750169479,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时11分，Castle Biosciences, Inc.股票出现波动，股价急速跳水5.16%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.98%。其相关个股中，Prophase Labs, Inc.、Oncocyte Corporation、Prenetics Global涨幅较大，Prophase Labs, Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为129.65%、6.41%、0.56%，振幅较大的相关个股有Oncocyte Corporation、Prophase Labs, Inc.、Applied Dna Sciences, Inc.，振幅分别为13.92%、13.74%、7.81%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061722112097838268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061722112097838268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2537393759","title":"Scotiabank：维持Castle Biosciences(CSTL.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由44.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537393759","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537393759?lang=zh_cn&edition=full","pubTime":"2025-05-21 23:52","pubTimestamp":1747842734,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Castle Biosciences(CSTL.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由44.00美元调整至40.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21235250577008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CSTL"],"gpt_icon":0},{"id":"2534779429","title":"Castle Biosciences, Inc.2025财年第一财季实现净利润-25.85百万美元，同比减少921.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534779429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534779429?lang=zh_cn&edition=full","pubTime":"2025-05-11 00:01","pubTimestamp":1746892891,"startTime":"0","endTime":"0","summary":"5月11日，Castle Biosciences, Inc.公布财报，公告显示公司2025财年第一财季净利润为-25.85百万美元，同比减少921.74%；其中营业收入为87.99百万美元，同比增加20.58%，每股基本收益为-0.90美元。从资产负债表来看，Castle Biosciences, Inc.总负债61.41百万美元，其中短期债务2.55百万美元，资产负债比为0.09，流动比率为0.10。机构评级：截至2025年5月11日，当前有9家机构对Castle Biosciences, Inc.目标价做出预测，其中目标均价为36.33美元，其中最低目标价为30.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511000443a479615e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511000443a479615e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL"],"gpt_icon":0},{"id":"2533694586","title":"Lake Street：维持Castle Biosciences(CSTL.US)评级，由买入调整至买入评级, 目标价由40.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694586","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533694586?lang=zh_cn&edition=full","pubTime":"2025-05-07 07:22","pubTimestamp":1746573735,"startTime":"0","endTime":"0","summary":"Lake Street：维持Castle Biosciences(CSTL.US)评级，由买入调整至买入评级, 目标价由40.00美元调整至35.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07072250177586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CSTL"],"gpt_icon":0},{"id":"1178241148","title":"异动解读 | Castle Biosciences股价盘中大跌14.21%，一季度业绩远低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1178241148","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178241148?lang=zh_cn&edition=full","pubTime":"2025-05-06 22:04","pubTimestamp":1746540297,"startTime":"0","endTime":"0","summary":"生物科技公司Castle Biosciences, Inc.周二盘中股价大跌14.21%，引起市场广泛关注。根据Castle Biosciences发布的财报显示，公司2025年第一季度调整后每股亏损为0.20美元，远低于分析师平均预期的0.07美元亏损。随着市场继续消化这一财报信息，Castle Biosciences股价在未来几个交易日可能会面临进一步的波动，投资者需密切关注公司后续的经营改善措施及市场反应。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"1134478552","title":"异动解读 | 业绩远低预期，Castle Biosciences盘中大跌14.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134478552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134478552?lang=zh_cn&edition=full","pubTime":"2025-05-06 22:04","pubTimestamp":1746540297,"startTime":"0","endTime":"0","summary":"生物科技公司Castle Biosciences, Inc.今日盘中大跌14.21%，股价走势引发市场广泛关注。根据Castle Biosciences最新发布的财报显示，公司2025年第一季度调整后每股亏损为0.20美元，远低于分析师平均预期的0.07美元亏损。尽管Castle Biosciences今年以来股价已累计下跌超过27%，但分析师对该公司的长期前景仍保持乐观态度。然而，考虑到本次财报业绩不佳，投资者可能需要重新评估公司的短期增长潜力。随着市场继续消化Castle Biosciences第一季度业绩，该股在未来几个交易日内可能会面临进一步的波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"2533632058","title":"Castle Biosciences, Inc.盘中异动 快速下挫9.07%报17.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533632058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533632058?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:31","pubTimestamp":1746538273,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时31分，Castle Biosciences, Inc.股票出现波动，股价大幅跳水9.07%。截至发稿，该股报17.05美元/股，成交量4.1508万股，换手率0.14%，振幅1.81%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.66%。其相关个股中，Prophase Labs, Inc.、Biodesix, Inc.、Xwell, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为3.00%、0.51%、0.44%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Prophase Labs, Inc.、Biodesix, Inc.，振幅分别为6.32%、5.50%、3.18%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213113a474161a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213113a474161a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"1155450605","title":"异动解读 | Castle Biosciences一季度业绩不及预期，股价盘前大跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155450605","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155450605?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:26","pubTimestamp":1746520000,"startTime":"0","endTime":"0","summary":"生物科技公司Castle Biosciences, Inc.今日盘前股价大跌6.13%，主要原因是该公司公布的2025年第一季度财报未能达到市场预期。根据最新发布的财报，Castle Biosciences第一季度调整后每股亏损为0.20美元，远低于分析师平均预期的0.07美元亏损。尽管Castle Biosciences今年以来股价已下跌27.4%，但分析师对该公司的前景仍保持乐观态度。随着市场对Castle Biosciences第一季度业绩的消化，未来几个交易日内该股可能会面临进一步的波动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Castle Biosciences一季度业绩不及预期，股价盘前大跌6.13%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"2527422766","title":"Castle Biosciences, Inc.盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527422766?lang=zh_cn&edition=full","pubTime":"2025-04-16 03:47","pubTimestamp":1744746467,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日03时47分，Castle Biosciences, Inc.股票出现异动，股价快速拉升5.03%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为1.22%。其相关个股中，Inotiv, Inc.、Oncocyte Corporation、Check-Cap Ltd.涨幅较大，Applied Dna Sciences, Inc.、Endra Life Sciences Inc.、Mainz Biomed N.V.较为活跃，换手率分别为91.96%、5.57%、3.85%，振幅较大的相关个股有燃石医学、Inotiv, Inc.、Prenetics Global Limited C/Wts 18/05/2027 ，振幅分别为23.71%、20.64%、19.19%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416034748aa2c7071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416034748aa2c7071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2518277687","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277687?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:43","pubTimestamp":1741617807,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时43分，Castle Biosciences, Inc.股票出现异动，股价快速下挫5.29%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.18%。其相关个股中，恩佐生化、Bioaffinity Technologies, Inc.、23Andme Holding Co.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、23Andme Holding Co.较为活跃，换手率分别为6.10%、2.68%、1.93%，振幅较大的相关个股有Inotiv, Inc.、23Andme Holding Co.、Exagen Inc.，振幅分别为20.23%、16.77%、15.17%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2518280964","title":"Castle Biosciences, Inc.2024财年实现净利润18.25百万美元，同比增加131.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518280964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518280964?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449618,"startTime":"0","endTime":"0","summary":"3月9日，Castle Biosciences, Inc.公布财报，公告显示公司2024财年净利润为18.25百万美元，同比增加131.76%；其中营业收入为3.32亿美元，同比增加50.91%，每股基本收益为0.66美元。从资产负债表来看，Castle Biosciences, Inc.总负债98.08百万美元，其中短期债务2.04百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月9日，当前有9家机构对Castle Biosciences, Inc.目标价做出预测，其中目标均价为39.67美元，其中最低目标价为36.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL"],"gpt_icon":0},{"id":"1158731355","title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","url":"https://stock-news.laohu8.com/highlight/detail?id=1158731355","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158731355?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116394,"startTime":"0","endTime":"0","summary":"Castle Biosciences公司股票今日盘中出现较大涨幅,引起了广泛关注。据报道,CSTL股价大涨5.12%,盘中最高达到22.36美元/股,换手率仅1.57%,振幅9.38%,成交量增加。分析人士指出,造成CSTL股价上涨的主要原因可能是公司不久前公布的最新财报数据表现出色。财报显示,CSTL实现营业收入3.32亿美元,净利润1825万美元,每股收益0.66美元,毛利2.59亿美元,市盈率36倍。总的来说,可见CSTL股价上涨与公司自身的业绩表现和融资发展前景密切相关。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"2517298864","title":"Castle Biosciences, Inc.盘中异动 股价大涨5.12%报22.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517298864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517298864?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:23","pubTimestamp":1741116233,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时23分，Castle Biosciences, Inc.股票出现异动，股价快速上涨5.12%。截至发稿，该股报22.36美元/股，成交量44.739万股，换手率1.57%，振幅9.38%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.98%。其相关个股中，Neuronetics, Inc.、Grail, Inc.、Opko健康涨幅较大，Ispecimen Inc.、Prophase Labs, Inc.、Neuronetics, Inc.较为活跃，换手率分别为16.91%、7.56%、7.06%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.、Biodesix, Inc.，振幅分别为36.22%、34.15%、33.66%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2514282320","title":"Castle Biosciences, Inc.盘中异动 早盘急速下跌7.24%报23.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514282320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514282320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Castle Biosciences, Inc.股票出现异动，股价大幅下跌7.24%。截至发稿，该股报23.45美元/股，成交量1.0393万股，换手率0.04%，振幅2.65%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.64%。其相关个股中，Oncocyte Corporation、Opko健康、Biodesix, Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Prophase Labs, Inc.较为活跃，换手率分别为4.28%、0.84%、0.75%，振幅较大的相关个股有Radnet, Inc.、Aclaris Therapeutics, Inc.、Sotera Health Company，振幅分别为8.75%、5.13%、4.64%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2514270363","title":"Baird：维持Castle Biosciences(CSTL.US)评级，由优于大市调整至优于大市评级, 目标价由36.00美元调整至37.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514270363","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514270363?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:28","pubTimestamp":1740752881,"startTime":"0","endTime":"0","summary":"Baird：维持Castle Biosciences(CSTL.US)评级，由优于大市调整至优于大市评级, 目标价由36.00美元调整至37.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28222848467016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CSTL"],"gpt_icon":0},{"id":"1100923571","title":"Castle Biosciences 2024年第四季度GAAP每股收益为$0.32，同比增涨，销售额为$86.311M，超出$81.911M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1100923571","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100923571?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:23","pubTimestamp":1740691404,"startTime":"0","endTime":"0","summary":"Castle Biosciences报告季度每股收益为$0.32。这相较于去年同期的每股亏损$，增长了420%。公司报告季度销售额为$86.311百万，超出分析师的预期$81.911百万，超出5.37%。这比去年同期的销售额$66.120百万增长了30.54%。以上内容来自Benzinga Earnings专栏，原文如下：Castle Biosciences  reported quarterly earnings of $0.32 per share. This is a 420 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $86.311 million which beat the analyst consensus estimate of $81.911 million by 5.37 percent.  This is a 30.54 percent increase over sales ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Castle Biosciences 2024年第四季度GAAP每股收益为$0.32，同比增涨，销售额为$86.311M，超出$81.911M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL"],"gpt_icon":0},{"id":"2514286857","title":"Castle Biosciences, Inc.盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286857?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:43","pubTimestamp":1740588221,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时43分，Castle Biosciences, Inc.股票出现波动，股价快速上涨5.00%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.11%。其相关个股中，Veracyte, Inc.、Grail, Inc.、Neuronetics, Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为10.23%、8.22%、5.18%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.，振幅分别为36.76%、28.66%、14.10%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227004341a255156d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227004341a255156d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2505216208","title":"Castle Biosciences, Inc.盘中异动 急速上涨5.05%报26.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505216208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505216208?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:25","pubTimestamp":1737473137,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时25分，Castle Biosciences, Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报26.20美元/股，成交量7.354万股，换手率0.26%，振幅3.45%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为1.56%。其相关个股中，Guardant Health, Inc.、Grail, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为18.36%、2.29%、1.99%，振幅较大的相关个股有Guardant Health, Inc.、安奈特保险、Neuronetics, Inc.，振幅分别为12.44%、10.76%、10.11%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232538986e3dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232538986e3dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2503570926","title":"Castle Biosciences, Inc.盘中异动 早盘快速下挫5.05%报24.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570926?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:35","pubTimestamp":1736868956,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时35分，Castle Biosciences, Inc.股票出现波动，股价快速下挫5.05%。截至发稿，该股报24.83美元/股，成交量18.0555万股，换手率0.64%，振幅6.12%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.19%。其相关个股中，Atlantic International Corp.、Oncocyte Corporation、Precipio, Inc.涨幅较大，Ispecimen Inc.、Precipio, Inc.、Neuronetics, Inc.较为活跃，换手率分别为2.11%、1.45%、1.37%，振幅较大的相关个股有Neuronetics, Inc.、T2 Biosystems, Inc.、Atlantic International Corp.，振幅分别为11.92%、10.63%、9.67%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423355696038b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423355696038b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2503458680","title":"Castle Biosciences, Inc.盘中异动 早盘股价大跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503458680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503458680?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778726,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Castle Biosciences, Inc.股票出现异动，股价急速下挫8.03%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.08%。其相关个股中，Neuronetics, Inc.、Atlantic International Corp.、Caredx, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Ispecimen Inc.较为活跃，换手率分别为17.51%、0.61%、0.51%，振幅较大的相关个股有Exagen Inc.、Neuronetics, Inc.、Castle Biosciences, Inc.，振幅分别为104.11%、16.37%、6.88%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223207960252df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223207960252df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.castlebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0285},{"period":"1month","weight":0.1227},{"period":"3month","weight":-0.0174},{"period":"6month","weight":-0.3961},{"period":"1year","weight":0.1008},{"period":"ytd","weight":-0.2585}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Castle Biosciences, Inc.于2007年9月12日在特拉华州注册成立。该公司是一家商业阶段的皮肤病癌症公司，致力于为医生及其患者提供个性化，临床可操作的基因组信息，以做出更准确的治疗决策。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.030345},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068437},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.002672},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084405},{"month":5,"riseRate":0.5,"avgChangeRate":0.014411},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.00564},{"month":7,"riseRate":0.666667,"avgChangeRate":0.092982},{"month":8,"riseRate":1,"avgChangeRate":0.191663},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.108717},{"month":10,"riseRate":0.333333,"avgChangeRate":0.043378},{"month":11,"riseRate":0.5,"avgChangeRate":-0.01521},{"month":12,"riseRate":0.666667,"avgChangeRate":0.113829}],"exchange":"NASDAQ","name":"Castle Biosciences, Inc.","nameEN":"Castle Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Castle Biosciences, Inc.,CSTL,Castle Biosciences, Inc.股票,Castle Biosciences, Inc.股票老虎,Castle Biosciences, Inc.股票老虎国际,Castle Biosciences, Inc.行情,Castle Biosciences, Inc.股票行情,Castle Biosciences, Inc.股价,Castle Biosciences, Inc.股市,Castle Biosciences, Inc.股票价格,Castle Biosciences, Inc.股票交易,Castle Biosciences, Inc.股票购买,Castle Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}